Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.
I think we are close to 10-11p, perhaps last sells out before the move
if it lasts we will see 10p here tomorrow morning
hmm, Does Crystal Amber have any contacts to help with Hurricane's takeover?
Decision about that was made on the 3rd December 2021
Brent $120 !!!
Oil over 3% higher now. Careful with selling today, this can explode any time.
yes, hedging makes sense, however we do not know if EU won't limit buying of the RU oil. If yes, then oil price can be even higher than 130 imo
OT I remember myself being in the Nighthawk Energy.
Believe me or not but our wells have been producing $18m USD of oil annually and the company has been placed into administration due to debt of just $20m. The bank did not agree to extend the deadline. The Delaware court in the US approved a sale of all assets as a best way to pay the debt.
Believe me or not, the court said that $20m offer (which only one arrived as there was no advertisement of the assets sale) was in the best interest for the company, loan provider and of course buyer.
All producing wells, all docs, experienced people got transferred to a neighbour company and wells are operating to date.
Imagine buying a company that generates $20m annually for $20m. Pay the debts quickly and here you go. Annual interest 100%. Court approved, deal done, shareholders lost all, including myself. Shareholders did not even have a chance to appeal as it was brought to the banktupcy court.
Here we got extremely lucky having that court on HUR side.
I think lads best to visit some lawyer before it's too late
that would make sense
That should be good for Genedrive if true.
Germany's health minister has cast doubt on the ability of lateral flow tests to detect Omicron.
The country is launching a study to assess their reliability when it comes to the variant, with the results expected in the next few weeks.
Health minister Karl Lauterbach said: "We do not know exactly how well these tests work for Omicron."